Stifel Financial Corp Genmab A/S Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Genmab A/S stock. As of the latest transaction made, Stifel Financial Corp holds 168,991 shares of GMAB stock, worth $3.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,991

Previous 174,927 3.39%

Holding current value

$3.48 Million

Previous $4.4 Million 6.26%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.84 - $28.48 $141,514 - $169,057	-5,936 Reduced 3.39%	168,991 $4.12 Million
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $1.46 Million - $1.76 Million	-58,001 Reduced 24.9%	174,927 $4.4 Million
Q1 2024 May 13, 2024	SELL	$26.43 - $32.77 $11.6 Million - $14.4 Million	-439,965 Reduced 65.38%	232,928 $6.97 Million
Q4 2023 Feb 12, 2024	SELL	$27.94 - $35.44 $983,935 - $1.25 Million	-35,216 Reduced 4.97%	672,893 $21.4 Million
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $755,307 - $904,569	-21,415 Reduced 2.94%	708,109 $25 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $395,430 - $454,004	-10,573 Reduced 1.43%	729,524 $27.7 Million
Q1 2023 May 12, 2023	BUY	$34.88 - $43.22 $123,719 - $153,301	3,547 Added 0.48%	740,097 $27.9 Million
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $35,185 - $48,989	-1,041 Reduced 0.14%	736,550 $31.2 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $641,305 - $7.6 Million	20,346 Added 2.84%	737,591 $23.7 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $11.7 Million - $16.8 Million	-435,845 Reduced 37.8%	717,245 $23.3 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $1.74 Million - $2.24 Million	-56,333 Reduced 4.66%	1,153,090 $41.7 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $451,495 - $593,099	12,587 Added 1.05%	1,209,423 $47.8 Million
Q3 2021 Nov 15, 2021	BUY	$41.55 - $48.72 $1.78 Million - $2.09 Million	42,948 Added 3.72%	1,196,836 $52.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $517,169 - $701,041	15,729 Added 1.38%	1,153,888 $47.1 Million
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $3.45 Million - $4.95 Million	-111,519 Reduced 8.92%	1,138,159 $37.4 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $4.6 Million - $5.57 Million	136,541 Added 12.27%	1,249,678 $50.8 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $5.34 Million - $6.25 Million	161,507 Added 16.97%	1,113,137 $40.8 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $17.1 Million - $28.9 Million	852,540 Added 860.37%	951,630 $32.3 Million
Q1 2020 May 14, 2020	BUY	$17.15 - $25.22 $38,536 - $56,669	2,247 Added 2.32%	99,090 $2.17 Million
Q4 2019 Feb 13, 2020	BUY	$18.88 - $24.14 $31,227 - $39,927	1,654 Added 1.74%	96,843 $2.21 Million
Q3 2019 Nov 13, 2019	BUY	$18.0 - $21.38 $1.71 Million - $2.04 Million	95,189 New	95,189 $1.99 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Genmab A/S Transaction History